/content/dam/www/people-profile-photos/p/amanda-phipps/amanda-phipps-d.jpg
Phipps
Amanda Phipps, PhD, MPH
- Associate Professor, Public Health Sciences Division, Fred Hutch
- Associate Professor of Epidemiology, University of Washington
Background
Dr. Amanda Phipps is an epidemiologist who identifies how aspects of tumor biology and lifestyle factors, like smoking and physical activity, affect cancer survival. Working with studies like the Genetics and Epidemiology of Colorectal Cancer Consortium, or GECCO, Dr. Phipps identifies genetic factors and tumor attributes that contribute to colorectal cancer patients’ prognosis. She also studies the relationship between obstructive sleep apnea and cancer. Another research interest focuses on risk factors related to triple-negative breast cancer and other molecular subtypes of the disease.
Education
PhD, University of Washington, Epidemiology, 2010
MPH, University of California, Berkeley, Epidemiology and Biostatistics, 2003
BA, Northwestern University, Molecular and Cell Biology, 2001
Research Interests
Dr. Phipps’ research interests span the fields of cancer epidemiology, molecular epidemiology, and clinical epidemiology. In particular, her work is focused on identifying ways in which cancer survival differs according to aspects of a patient’s lifestyle (e.g., smoking, physical activity) and aspects of tumor biology (e.g., KRAS mutation status, microsatellite instability, tumor microbiome). Her current projects focus on the relationship of modifiable lifestyle behaviors and the tumor-associated microbiome with survival in individuals with biologically-distinct subtypes of colorectal cancer, and on the relationship between obstructive sleep apnea and cancer. She is also working to identify the role of lifestyle factors in how cancer patients respond to certain forms of cancer treatment. In addition to her current work in colorectal cancer survival, she has an interest in molecular subtypes of breast cancer, particularly in risk factors for the poor-prognosis triple-negative subtype of breast cancer.